Here we describe pedigrees and patients associated with both intermediate and full-length ATXN2 expansions. In all cases except the Montreal patient, the most frequent ALS-associated mutation in C9ORF72 [10] was excluded. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.